ACSL5 and colorectal adenocarcinoma: found that the high activity of ACSL5 enhances caspase-3 and caspase-7 activity to promote apoptosis regulated by TP53 status via WNT2B palmitoylation in enterocytes and colorectal adenocarcinomas (60).